News
Article
PTSM: Pharmaceutical Technology Sourcing and Management
PTSM: Pharmaceutical Technology Sourcing and Management
Author(s):
Increased competition, the rising role of emerging markets, and targeted opportunities in niche segments are factors influencing the generic-drug market and related supply base.
Shifting fundamentals in the innovator-drug market are helping to drive change in the generic-drug market. Despite strong opportunity presented in the near term by a wave of patent expirations, the generic-drug industry has its own set of challenges and opportunities. Generic-drug companies face increased competition not only within the sector, but from newer entrants, including from the pharmaceutical majors and emerging-market players. In response, generic-drug companies have been consolidating and partnering to build economies of scale, improve their access to emerging markets, and build their technological expertise in select sectors, such as follow-on biologics (FOBs). These issues also are influencing the composition and direction of the supply base of generic active pharmaceutical ingredient (APIs) manufacturers.
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.